IRCT20220211053992N27招募中Unknown
In vivo Bioequivalence study of Bisoprolol H (10/25) tablet manufactured by AaniDarman Pharmaceutical Co. Compared to innovator Product
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- All
入选标准
- •General Health (in terms of Liver, Heart and Kidney diseases)
- •Age between 18 to 59 years
排除标准
- •History of cardiovascular, liver, and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
招募中
Unknown
Bioequivalence study of bisoprolol fumarate hydrochlorothiazide tablet 10/25 mgIRCT20230222057495N9Sami Saz Pharmaceutical Company24
已完成
3 期
Evaluation of the effect of bisoprolol in the control of atrial fibrillatioAtrial fibrillation in patients undergoing coronary artery bypass grafting.Atrial fibrillation and flutterIRCT20210121050095N1Qazvin University of Medical Sciences114
已完成
2 期
Evaluation of preventive effect of bisoprolol in sub clinical Heart failureIRCT20240609062050N1Iran University of Medical Sciences70
已完成
4 期
To assess the Efficacy and tolerability of Bisoprolol in patients with newly diagnosed Stage I essential hypertension.CTRI/2010/091/000632Merck Serono Merck Ltd2,000
已完成
不适用
Evaluation of pharmacokinetics of bisoprolol after apprication of a bisoprolol patch preparation for an 8 h.JPRN-UMIN000023024Kaetsu Hospotal10